Phase II and phase III trials: docetaxel/irinotecan versus docetaxel/cisplatin in advanced non-small-cell lung cancer (WJTOG 9803). [electronic resource]
Producer: 20040123Description: 178-9 p. digitalISSN:- 1525-7304
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.